Management and Outcome of Coronavirus Disease 2019 (COVID-19) in Pediatric Cancer Patients: A Single Centre Experience from a Developing Country

Few cancer centers from developing countries have described the impact of COVID-19 on pediatric cancer patients. Seventy-six pediatric oncology patients with COVID-19 infection were recruited. Most patients had a favourable outcome with sixty-day overall survival of 86.8%. Mortalities occurred only among patients with critical forms of infection. The potential benefits  of remdesivir in pediatric oncology patients require further studies.

Source: Clinical Lymphoma, Myeloma and Leukemia - July 26, 2021 Category: Hematology Authors: Mahmoud Hammad, Lobna Shalaby, Iman Sidhom, Nancy Sherief, Ibrahim Abdo, Sonia Soliman, Youssef Madeny, Reem Hassan, Shaimaa Elmeniawy, Nagwa Khamis, Iman Zaki, Tarek Mansour, Mohamed Gamal El-Ansary, Ahmed El-Halfawy, Sherif Abouelnaga, Alaa Elhaddad Source Type: research